Lally John, Byrne Fintan, Walsh Elizabeth
Department of Psychiatry, National University of Ireland, Galway (NUIG), Galway, Ireland.
BMJ Case Rep. 2012 Jun 21;2012:bcr0220125842. doi: 10.1136/bcr.02.2012.5842.
The authors report the case of a 20-year-old man who presented with a de novo episode of hypomania subsequent to the initiation of quinacrine for treatment resistant giardiasis. The hypomanic episode commenced some 20 days after the successful completion of a week long course of quinacrine 100 mg three times daily. The hypomanic episode was treated with olanzapine 10 mg daily. Two months subsequent to this, the patient developed a moderate depressive episode which was treated with escitalopram and olanzapine. One month after the resolution of the depressive episode, he once again presented with a hypomanic episode. The recurring episodes of discrete mood disturbance all occurred within 5 months of the commencement of quinacrine in an individual with no personal history of affective disorders.
作者报告了一例20岁男性病例,该患者在开始使用奎纳克林治疗耐药贾第虫病后出现了一次新发的轻躁狂发作。轻躁狂发作在成功完成为期一周的每日三次100毫克奎纳克林疗程约20天后开始。轻躁狂发作采用每日10毫克奥氮平进行治疗。在此之后两个月,患者出现了中度抑郁发作,采用艾司西酞普兰和奥氮平进行治疗。抑郁发作缓解一个月后,他再次出现轻躁狂发作。在一名无情感障碍个人史的患者中,离散性情绪障碍的反复发作出现在开始使用奎纳克林后的5个月内。